ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID PARISH MD

Internal Medicine

462

$18.2K

72
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

7%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $56

LISA BERNSTEIN M.D.

Internal Medicine

1,961

$119K

71
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $56

SARA CHAPPELL KNABE

Internal Medicine

1,184

$45.9K

71
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

31%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $56

NEETA PATEL M.D.

Internal Medicine

841

$51.3K

70
59 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $56

CHRISTOPHER PHILLIPS MD

Internal Medicine

457

$27.5K

70
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $56

JAMES THOMAS MD

Internal Medicine

878

$42.7K

70
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

SUNITHA KALUVEHALLIMATTA MBBS

Internal Medicine

754

$30.3K

69
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

GUILDA SAINT-FLEUR M.D.

Internal Medicine

1,134

$73.8K

69
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $56

CHRISTINA HENDRY M.D

Internal Medicine

710

$34.1K

68
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

WIBISONO HARTOJO M.D.

Internal Medicine

1,250

$52.5K

68
31 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

25%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $56

PANKIL PATEL M.D.

Internal Medicine

1,045

$68.1K

68
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$65
Average prescription price

Avg: $56

SUSMITA PARASHAR MD

Internal Medicine

436

$26.1K

67
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $56

ERNEST COKER MD

Internal Medicine

840

$43.9K

66
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

SUE BRENNER M.D.

Internal Medicine

1,188

$79.4K

65
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $56

YOHANNES BELACHEW M.D

Internal Medicine

1,044

$30.2K

65
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 26%

$29
Average prescription price

Avg: $56

DAVID ROWAN

Internal Medicine

607

$29.6K

64
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

36%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

RENE HARPER M.D.

Internal Medicine

410

$124K

64
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

59%
prescriptions for brand name drugs

Avg: 26%

$303
Average prescription price

Avg: $56

PRAVINKUMAR PATEL M.D.

Internal Medicine

1,023

$40.1K

64
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $56

WILLIAM SALAZAR MD

Internal Medicine

854

$31.8K

63
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $56

VIGELO SERVERA M.D.

Internal Medicine

1,436

$101K

63
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$70
Average prescription price

Avg: $56

KENIL SIDHPURA MD

Internal Medicine

568

$19.5K

63
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $56

MYRTLE WILDER CNP

Internal Medicine

734

$36.9K

62
44 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $56

LAURA DAVIDSON MD

Internal Medicine

2,020

$114K

62
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $56

MARILYN DIGAMON-BELTRAN MD

Internal Medicine

837

$28.7K

62
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$34
Average prescription price

Avg: $56

CHARLES DEMOSTHENES M.D.

Internal Medicine

493

$12.2K

62
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 26%

$25
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank